Sp. Soltoff et al., BLOCKADE OF ATP BINDING-SITE OF P(2) PURINOCEPTORS IN RAT PAROTID ACINAR-CELLS BY ISOTHIOCYANATE COMPOUNDS, Biochemical pharmacology, 45(9), 1993, pp. 1936-1940
Extracellular ATP activates a P2Z-type purinergic receptor (purinocept
or) in rat parotid acinar cells that increases the intracellular free
Ca2+ concentration via the entry of extracellular Ca2+ through an ATP-
sensitive cation channel (Soltoff et al., Am J Physiol 262: C934-C940,
1992). To learn more about the ATP binding site of the purinoceptor,
we examined the effects of several stilbene isothiocyanate analogs of
DIDS (4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid), which block
the binding of [P-32]ATP to intact parotid cells (McMillian et al., B
iochem J 255: 291-300, 1988) and blocked the activation of the P2Z pur
inoceptor. The ATP-stimulated Ca-45(2+) uptake was blocked by DIDS, H2
DIDS (dihydro-DIDS; 4'-diisothiocyanatodihydrostilbene-2,2'-disulfonic
acid), and SIT'S cetamido-4'-isothiocyanatostilbene-2,2'-disulfonic a
cid), but not by DNDS (4,4'-dinitrostilbene-2,2'-disulfonic acid), a s
tilbene disulfonate compound lacking isothiocyanate (SCN-) groups, or
by KSCN. The potency of the stilbene disulfonates was related to the n
umber of isothiocyanate groups on each compound. Under the experimenta
l conditions, the IC50 value of DIDS (approximately 35 muM), which has
two SCN-groups, was much lower than that of SITS (approximately 125 m
uM), which has only one SCN- group. The inhibitory effects of DIDS app
eared to be much more potent than those of SITS due to the kinetics of
their binding to the purinoceptors. Eosin-5-isothiocyanate (EITC) and
fluoroscein-5-isothiocyanate (FITC), non-stilbene isothiocyanate comp
ounds with single SCN- groups, also blocked the response to ATP and we
re less potent than DIDS. Trinitrophenyl-ATP (TNP-ATP), an ATP derivat
ive that is not an effective agonist of the parotid P2Z receptor, bloc
ked the covalent binding of DIDS to the plasma membrane, suggesting th
at ATP and DIDS bind to the same site. Reactive Blue 2 (Cibacron Blue
3GA), an anthraquinone-sulfonic acid derivative that is a noncovalent
purinergic antagonist, also blocked the covalent binding of DIDS to th
e plasma membrane. These results suggest that isothiocyanate compounds
interact with the ATP binding site of this P2 purinoceptor, and that
isothiocyanate groups make an important contribution in determining th
e effectiveness of the stilbene disulfonate compounds in blocking the
binding of nucleotide agonists to this purinoceptor.